Because of their popularity, many GLP-1 RAs like Ozempic and Wegovy are experiencing supply shortages

After 72 weeks: Participants taking 6 mg of orforglipron lost an average of 7.5% of their body weight (equivalent to 9 mg of Foundayo) Participants taking 12 mg or 37 mg of orforglipron lost an average of 8.4% and 11.2%, respectively (equivalent to 14.5 mg or 17.2 mg of Foundayo, respectively) Side effects and risks of GLP-1s The most common side effects from these medicines are mild gastrointestinal (GI) issues, such as: Vomiting Diarrhea Abdominal pain Rare but serious side effects of GLP-1s may include: Pancreatitis, or inflammation of the pancreas Gallbladder disease (including gallstones or gallbladder inflammation) Low blood sugar ( hypoglycemia ), particularly in people who also take insulin or certain pills for diabetes Severe allergic reactions Severe gastrointestinal reactions, which may lead to dehydration and related kidney problems Diabetic retinopathy complications in people with this eye disease Risk of pulmonary aspiration ( stomach contents entering the lungs) during surgery in people undergoing deep sedation or anesthesia GLP-1s also carry a boxed warning because they caused thyroid C-cell tumors in studies of rats

In this study, an increase in total glutathione level in the magnesium treated animals was observed which suggests a potentiation of glutathione production (Table 2)
For the last year or two, Id been battling what I can only describe as low-grade brain fog
Related Doctor-Led Treatments & Evidence-Based Resources Related Services at The Face Clinic (South Delhi) NAD Therapy Targeted metabolic and cellular energy support under medical supervision
and one presently under FDA review for the same (tirzepatide or Mounjaro)